Filing Details

Accession Number:
0001601485-22-000044
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-05-27 16:19:36
Reporting Period:
2021-02-09
Accepted Time:
2022-05-27 16:19:36
Original Submission Date:
2021-02-11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601485 Angion Biomedica Corp. ANGN () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199070 F Victor Ganzi C/O Angion Biomedica Corp.
51 Charles Lindbergh Blvd.
Uniondale NY 11553
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-09 614,310 $6.43 1,069,837 No 4 X Direct
Common Stock Disposition 2021-02-09 246,720 $16.00 823,117 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Disposition 2021-02-09 614,310 $0.00 614,310 $6.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-07-05 No 4 X Direct
Footnotes
  1. On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.